
Joseph J. Kukella
Examiner (ID: 18482, Phone: (571)272-4679 , Office: P/2913 )
| Most Active Art Unit | 2913 |
| Art Unit(s) | 2961, 2913 |
| Total Applications | 1553 |
| Issued Applications | 1431 |
| Pending Applications | 3 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19904098
[patent_doc_number] => 12281094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Preparation method of racemic nicotine
[patent_app_type] => utility
[patent_app_number] => 17/547254
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547254 | Preparation method of racemic nicotine | Dec 9, 2021 | Issued |
Array
(
[id] => 18964140
[patent_doc_number] => 11897890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/547983
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 27552
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547983 | 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof | Dec 9, 2021 | Issued |
Array
(
[id] => 19127131
[patent_doc_number] => 20240132484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX
[patent_app_type] => utility
[patent_app_number] => 18/265191
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265191
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265191 | BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX | Dec 2, 2021 | Pending |
Array
(
[id] => 18971835
[patent_doc_number] => 20240051927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => FLOW SYNTHESIS OF RDX
[patent_app_type] => utility
[patent_app_number] => 18/256548
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256548
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/256548 | FLOW SYNTHESIS OF RDX | Nov 30, 2021 | Pending |
Array
(
[id] => 18920545
[patent_doc_number] => 20240023549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => FUNGICIDAL ARYL AMIDINES
[patent_app_type] => utility
[patent_app_number] => 18/253822
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253822
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253822 | FUNGICIDAL ARYL AMIDINES | Nov 21, 2021 | Pending |
Array
(
[id] => 17443634
[patent_doc_number] => 20220064139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => FLUOROLACTONE AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/521155
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/521155 | Fluorolactone and method for producing same | Nov 7, 2021 | Issued |
Array
(
[id] => 18223867
[patent_doc_number] => 20230062861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => PPARg MODULATORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/521666
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 184648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17521666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/521666 | PPARg MODULATORS AND METHODS OF USE | Nov 7, 2021 | Pending |
Array
(
[id] => 17428349
[patent_doc_number] => 20220056057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Novel Lipids
[patent_app_type] => utility
[patent_app_number] => 17/520287
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520287
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520287 | Cardiopathy-reducing phosphodiester lipids | Nov 4, 2021 | Issued |
Array
(
[id] => 17426782
[patent_doc_number] => 20220054490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/517620
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17517620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/517620 | Hydantoin derivatives useful as Kv3 inhibitors | Nov 1, 2021 | Issued |
Array
(
[id] => 17399485
[patent_doc_number] => 20220041575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHODS OF MANUFACTURING OF NIRAPARIB
[patent_app_type] => utility
[patent_app_number] => 17/452928
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17452928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/452928 | Methods of manufacturing of niraparib | Oct 28, 2021 | Issued |
Array
(
[id] => 17399484
[patent_doc_number] => 20220041574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => PYRAZOLE AMINE REACTIVE CRYSTALLIZATION
[patent_app_type] => utility
[patent_app_number] => 17/505745
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505745
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/505745 | PYRAZOLE AMINE REACTIVE CRYSTALLIZATION | Oct 19, 2021 | Abandoned |
Array
(
[id] => 17413954
[patent_doc_number] => 20220048858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
[patent_app_type] => utility
[patent_app_number] => 17/506331
[patent_app_country] => US
[patent_app_date] => 2021-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/506331 | Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides | Oct 19, 2021 | Issued |
Array
(
[id] => 20040799
[patent_doc_number] => 20250179021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => Method For Preparing Meta-Functionalized Pyridine Compound
[patent_app_type] => utility
[patent_app_number] => 18/038029
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18038029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/038029 | Method for preparing meta-functionalized pyridine compound | Oct 14, 2021 | Issued |
Array
(
[id] => 17850455
[patent_doc_number] => 20220280496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/500039
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500039 | PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR | Oct 12, 2021 | Abandoned |
Array
(
[id] => 18808533
[patent_doc_number] => 20230382866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => PROCESS FOR THE PREPARATION OF 5-(1-CYANOCYCLOPROPYL)-PYRIDINE-2-CARBOXYLIC ACID ESTERS AMIDES AND NITRILES
[patent_app_type] => utility
[patent_app_number] => 18/248289
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248289
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248289 | PROCESS FOR THE PREPARATION OF 5-(1-CYANOCYCLOPROPYL)-PYRIDINE-2-CARBOXYLIC ACID ESTERS AMIDES AND NITRILES | Oct 7, 2021 | Pending |
Array
(
[id] => 17704490
[patent_doc_number] => 20220204496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PROCESS FOR PREPARING 5-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]-METHYL]-2,4-THIAZOLIDINEDIONE AND SALTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/479838
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479838 | Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-methyl]-2,4-thiazolidinedione and salts thereof | Sep 19, 2021 | Issued |
Array
(
[id] => 18980087
[patent_doc_number] => 11905247
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Compounds as neurokinin-1 receptor antagonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/476028
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 22935
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17476028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/476028 | Compounds as neurokinin-1 receptor antagonists and uses thereof | Sep 14, 2021 | Issued |
Array
(
[id] => 17720408
[patent_doc_number] => 20220213128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease
[patent_app_type] => utility
[patent_app_number] => 17/473032
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17473032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/473032 | L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease | Sep 12, 2021 | Abandoned |
Array
(
[id] => 18753889
[patent_doc_number] => 20230357212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => THIOPHENOXIME AND FURANOXIME SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 18/044850
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044850
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044850 | THIOPHENOXIME AND FURANOXIME SCAFFOLDS | Sep 9, 2021 | Pending |
Array
(
[id] => 17274354
[patent_doc_number] => 20210380552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => APPARATUS FOR CANNABINOL GENERATION AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/411607
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411607
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/411607 | APPARATUS FOR CANNABINOL GENERATION AND METHODS OF USING THE SAME | Aug 24, 2021 | Abandoned |